Growth and Plasma Amino Acid Levels in Infants With Cow's Milk Protein Allergy and Treated With a Newly Innovated Amino Acid Formula (NAAF) Compared to a Commercial Amino Acid Formula (AAF)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cow Milk Allergy
- Sponsor
- Mahidol University
- Enrollment
- 81
- Locations
- 1
- Primary Endpoint
- Growth and protein status
- Status
- Active, not recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
The purpose of this study is to determine growth and protein status of infants with cow's milk protein allergy and treated with a newly innovated amino acid formula compared to those with a commercial amino acid formula.
Detailed Description
Severe cases of cow's milk protein allergy are treated with the amino acid formula. The amino acid formula is composed of essential and non-essential amino acids, vegetable oils with or without MCT oil, and glucose polymer from various carbohydrate sources. Such formula is also fortified by minerals, trace elements,and vitamins.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Singleton
- •Clinical diagnosis of cow's milk protein allergy
Exclusion Criteria
- •Other diseases
Outcomes
Primary Outcomes
Growth and protein status
Time Frame: 4 weeks
* compare body weight, length, head circumference, triceps skin fold thickness, mid-arm circumference, and arm muscle area between NAAF and AAF groups * compare plasma amino acids, serum albumin, blood urea nitrogen, and creatinine between NAAF and AAF groups
Secondary Outcomes
- Growth(4 weeks)